Federal Rules: MEDICARE DRUG PRICE NEGOTIATION PROGRAM: FINAL GUIDANCE, IMPLEMENTATION OF SECTIONS 1191 -- 1198 OF THE SOCIAL SECURITY ACT FOR INITIAL PRICE APPLICABILITY YEAR 2027 AND MANUFACTURER EFFECTUATION OF THE MAXIMUM FAIR PRICE IN 2026 AND 2027 | U.S. GAO
Agency
Department of Health and Human Services
Subagency
Centers for Medicare & Medicaid Services
Type
Major
Description
MEDICARE DRUG PRICE NEGOTIATION PROGRAM: FINAL GUIDANCE, IMPLEMENTATION OF SECTIONS 1191 -- 1198 OF THE SOCIAL SECURITY ACT FOR INITIAL PRICE APPLICABILITY YEAR 2027 AND MANUFACTURER EFFECTUATION OF THE MAXIMUM FAIR PRICE IN 2026 AND 2027
Priority
Significant/Substantive
Effective
Received
Control Number
210088